News

In this pilot study, older adults who practiced yoga did better on measures of verbal and visual memory and executive function than those in memory training classes.

The author's enthusiasm and love for his work shines through in every page of this new book.

With over 10,000 mental health related smartphone apps out there, how can a psychiatrist determine which are useful and which may be harmful? Chair of the American Psychiatric Association’s Workgroup on SmartPhone Apps offers tips in this brief video.

Most of us listen in one way or another. But listening can be taken for granted, even in psychiatry.

It is vital that psychiatrists are able to identify and characterize cannabis use disorders; provide education; and offer effective, evidence-based treatments. This article provides a brief overview of each of these topics.

This article summarizes data on e-cigarettes, provides recommendations and resources to learn more, and emphasizes the evidence for treating tobacco (traditional cigarettes) addiction in people with mental illness.

This article reviews current literature on insomnia and alcohol use disorders and highlights assessment and treatment of sleep disorders in patients with comorbid alcohol abuse.

Because comorbid substance abuse is the rule rather than the exception in individuals with ADHD, accurate diagnosis, prognosis, and management of ADHD is challenging even for the most skilled practitioners.

A novel neuromodulatory intervention for an often-overlooked but nonetheless damaging effect of schizophrenia.

What is integrated care anyway?

The articles in this 2-part Special Report spotlight the issue of poor adherence, particularly medication adherence, and take on some of the multiple areas where interventions may be possible.

This article explores how motivational pharmacotherapy and motivational enhancement therapy can galvanize depressed patients to get well.

Successful culturally adapted interventions to improve adherence among Latino patients with depression and schizophrenia confirm how important it is to understand a patient’s entire sociocultural environment.

In psychiatry, things happen slowly-but if you’re not in a hurry yourself, the patient opens a window and shows you the world.

Monday, July 1st...Twenty-two new residents...All with perfect teeth...

Significant progress has been made in containing the opioid epidemic, but new threats loom. Thomas Kosten, MD, an addiction psychiatrist, takes a brief look.

Brian Miller joins the Editorial Board of Psychiatric Times.

COUTERPOINT: A small number of psychiatrists have been critical of our profession’s restraint regarding public comments by psychiatrists about the mental health of the 45th President.

POINT: After 41 years of membership, a psychiatrist resigns from the APA after it holds its ground on the Goldwater Rule.

While patients with restless legs syndrome may be successfully treated with a number of medications, comorbid psychiatric conditions present a unique challenge because many commonly prescribed psychiatric medications may worsen RLS symptoms.

We psychiatrists can't solve the world's political problems, but we can help those who are affected by them. Suggestions here.

A window into what your colleagues actually think and do.

Interaction between the brain and behavior implies that comprehensive progress cannot be made to relieve the suffering of patients without systematically addressing the brain basis of such conditions.

Have you considered using pharmacogenomic testing in your practice?

Numerous lines of evidence suggest a correlation between cannabis consumption and a variety of psychiatric conditions, including cannabis-induced psychosis.

Her mention of gardens got me to thinking, not just about fragrant flowers but also about “symptom substitution,” an old-time favorite of behavioral psychologists. Which activities most resemble hair-pulling? Weeding, for one.

Here: a plethora of treatment options, including mood-lifting stabilizers, non-antidepressants, psychotherapy, and lifestyle interventions.

Alzheimer disease-or dementia with Lewy bodies? Recently revised consensus criteria can help you solve this diagnostic dilemma.

How widely used is this “gold-standard” antipsychotic?

Got a challenging case-a patient for whom the diagnosis is unclear or uncertain? Want a diagnostic opinion? This is a call for cases. Michael First, MD-a nationally recognized expert on psychiatric diagnosis and assessment issues-will review details and offer insights on select cases.